Deutsche Bank remains very cautious on the bigger, broad-based semiconductor capital equipment companies, despite what appears to be interesting entry points for the sector leaders.
These five well-known stocks may be laggards but they look like they have solid upside potential, and all can help add alpha to portfolios.
These are four outstanding stocks for investors to add to portfolios for a gaming and lodging presence. They all look poised for a solid fall and football gambling season.
The top analyst upgrades, downgrades and initiations seen on Monday included Amgen, Chipotle Mexican Grill, Lam Research, Netgear, Teva Pharmaceutical and Western Digital.
These four top oil exploration and production companies are all trading at a discount to the NYMEX net asset value and offer investors some very exciting potential upside.
We screened our 24/7 Wall St. research database and found five stocks trading under the $10 level that could provide investors with some solid upside potential.
The exchanges and the online brokers traded down over the past month and may be offering investors a very good entry point in front of third-quarter results.
These five large-cap tech leaders that made the Goldman Sachs Conviction List all make good sense for more aggressive growth stock portfolios.
These three purveyors of burgers and much more could be poised for a solid rest of 2018 and 2019 as lower beef pricing could push up profits.
Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term, and the sector that rated highest was biotechnology.
These four top stocks have not gone up in tandem with oil pricing, and some are offering outstanding entry points. They are outstanding long-term buys for growth portfolios looking for income.
These six incredible companies dominate the aerospace and defense sector and should continue to do so in the years to come.
The technology sector is not cheap, but companies with solid recurring revenues can fare well in an environment in which taxes are lower and growth in the economy is solid.
Income-minded investors with a higher risk tolerance for dividend-paying equities can still find solid value even in today’s pricey market. These five stocks come with outstanding regular and dependable dividends of at least 4%.
Jefferies highlights the firm's top growth stocks to buy each week, and recently four top biotech stocks made the cut. They all make good sense now, and all have outstanding upside potential.
These five tech laggards have big upside to the Merrill Lynch price targets and also offer investors perhaps a more comfortable entry point.
Here are five stocks for aggressive accounts that look to get share count leverage on companies that have sizable upside potential.
As we are in a late cycle market, it makes sense to look for value and for some safety, and the analysts at Oppenheimer might be on to the sector that has both.
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
These companies pay reliable dividends, and if you can stand the potential roller coaster ride, you may have a nice steady stream of hefty income.
